Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Gas Relief

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Dimethicone 125 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2020
Label revision date
December 4, 2024
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Dimethicone 125 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2020
Label revision date
December 4, 2024
Manufacturer
Meijer Distribution, Inc.
Registration number
M002
NDC root
79481-0635
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Meijer® Extra Strength Gas Relief is a chewable tablet that contains 125 mg of simethicone, an active ingredient that helps relieve pressure, bloating, and discomfort commonly associated with gas. These tablets come in a pleasant peppermint crème flavor and are designed to provide quick relief from uncomfortable gas symptoms.

This product is similar to Gas-X® Extra Strength and is available in a package containing 18 tablets. If you're experiencing gas-related discomfort, Meijer® Extra Strength Gas Relief may be a helpful option to consider for easing your symptoms.

Uses

If you're experiencing discomfort from pressure, bloating, or a feeling of fullness often associated with gas, this medication can help provide relief. It's designed specifically to address these common digestive issues, making your day-to-day life more comfortable.

Rest assured, there are no known teratogenic effects (which means it doesn't cause birth defects) associated with this medication, so it is considered safe in that regard.

Dosage and Administration

It's important to follow the dosage instructions carefully to ensure your safety and the effectiveness of the medication. You should not take more than the directed amount. If you are an adult or a child aged 12 years and older, you can take 1 or 2 chewable tablets as needed after meals and at bedtime. Make sure to chew or crush the tablets completely before swallowing; do not swallow them whole.

Be mindful not to exceed 4 chewable tablets in a 24-hour period unless your doctor has instructed you to do so. If you have a child under 12 years old, it's best to consult a doctor before giving them this medication. Always prioritize safety and follow these guidelines for the best results.

What to Avoid

There are no specific contraindications, controlled substance classifications, or risks of abuse, misuse, or dependence associated with this medication. This means that, based on the available information, there are no particular situations or conditions under which you should avoid using it. Always consult with your healthcare provider for personalized advice and to ensure that this medication is appropriate for your individual health needs.

Side Effects

It's important to keep this medication out of reach of children to prevent accidental ingestion. While the provided information does not list specific side effects or adverse reactions, always consult your healthcare provider for any concerns or questions regarding your treatment. If you experience any unusual symptoms, be sure to seek medical advice promptly.

Warnings and Precautions

You can feel reassured that there are no specific warnings or precautions associated with this medication. It is designed for safe use without the need for laboratory tests or special monitoring.

If you ever have concerns or experience unusual symptoms while taking this medication, it’s always a good idea to consult your doctor for guidance. Your health and safety are important, so don’t hesitate to reach out if you need assistance.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health. Remember, timely intervention can make a significant difference.

Pregnancy Use

When it comes to using simethicone chewable tablets during pregnancy, there is currently no specific information available about their safety, recommended dosage, or any special precautions you should take. This means that while there are no known risks outlined, it’s always best to consult with your healthcare provider before taking any medication during pregnancy. They can provide personalized advice based on your individual health needs and circumstances.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of simethicone for nursing mothers. Additionally, there is no information indicating that simethicone is excreted in breast milk or that it poses any risk to your infant. This means you can use simethicone without concern for its effects on your milk production or your baby's health.

Pediatric Use

It's important to keep this medication out of reach of children to ensure their safety. For adults and children aged 12 years and older, the recommended dosage is 1 or 2 chewable tablets taken as needed after meals and at bedtime. However, you should not exceed 4 chewable tablets in a 24-hour period unless directed by a doctor.

If your child is under 12 years old, it's essential to consult a doctor before giving them this medication. Always prioritize their health and safety by following these guidelines closely.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider before starting the medication. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment is safe and effective for your specific condition. They can help determine the best approach for managing your health, especially if you have concerns about your kidneys.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to discuss any concerns regarding your liver health and how it may relate to your treatment. They can help ensure that you receive the safest and most effective care.

Drug Interactions

It's great to know that there are no reported drug interactions or laboratory test interactions with this medication. However, it's still very important to discuss all your current medications and any lab tests you may be undergoing with your healthcare provider. This ensures that they can provide you with the safest and most effective care tailored to your needs. Always keep an open line of communication about your health to avoid any potential issues.

Storage and Handling

To ensure the best performance of your product, store it at room temperature, ideally around 25°C (77°F). It’s acceptable for the temperature to vary between 15°-30°C (59°-86°F), but make sure to keep it away from moisture, as this can affect its quality.

When handling the product, be cautious and check the packaging carefully. If the outer package is opened or if the blister (the sealed compartment that holds the product) is torn or broken, do not use it. This tamper-evident feature is important for your safety, so always ensure the packaging is intact before use.

Additional Information

You can take this medication orally by chewing or crushing the tablets completely before swallowing. If you are an adult or a child aged 12 years and older, you can take 1 or 2 chewable tablets as needed after meals and at bedtime, but do not exceed 4 tablets in a 24-hour period unless your doctor advises otherwise. If you are under 12 years old, please consult a doctor for guidance on the appropriate dosage.

FAQ

What is Meijer® Extra Strength Gas Relief used for?

Meijer® Extra Strength Gas Relief is used for the relief of pressure, bloating, and fullness commonly referred to as gas.

What is the active ingredient in Meijer® Extra Strength Gas Relief?

The active ingredient is Simethicone, which is present at a dosage of 125 mg per chewable tablet.

How should I take Meijer® Extra Strength Gas Relief?

You should chew or crush the tablets completely before swallowing. Adults and children 12 years and over can take 1 or 2 tablets as needed after meals and at bedtime, not exceeding 4 tablets in 24 hours unless directed by a doctor.

Are there any contraindications for using Meijer® Extra Strength Gas Relief?

No specific contraindications are listed for Meijer® Extra Strength Gas Relief.

What should I do if the package is opened or damaged?

Do not use the product if the package is opened or if the blister unit is torn, broken, or shows any signs of tampering.

Is Meijer® Extra Strength Gas Relief safe to use during pregnancy?

There is no specific information regarding the safety of Meijer® Extra Strength Gas Relief during pregnancy.

Can children use Meijer® Extra Strength Gas Relief?

Children under 12 years should ask a doctor before using this product.

How should I store Meijer® Extra Strength Gas Relief?

Store the product at 25°C (77°F), with permitted excursions between 15°-30°C (59°-86°F), and protect it from moisture.

What flavor do the chewable tablets come in?

The chewable tablets are flavored with Peppermint Crème.

Where can I find more information about Meijer® Extra Strength Gas Relief?

You can visit the website www.meijer.com for more information.

Packaging Info

Below are the non-prescription pack sizes of Gas Relief (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Gas Relief.
Details

Drug Information (PDF)

This file contains official product information for Gas Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

Meijer® Extra Strength gas relief is a chewable tablet formulation containing 125 mg of the active ingredient simethicone. This product is indicated for the relief of pressure, bloating, and discomfort associated with gas. Each package contains 18 tablets flavored with peppermint crème. The tablets are designed to be chewed or crushed completely before swallowing.

The product is tamper evident; it should not be used if the package is opened or if the blister unit is torn, broken, or shows any signs of tampering. This product is distributed by Meijer Distribution, Inc., located in Grand Rapids, MI 49544, and is not manufactured or distributed by GSK Consumer Healthcare S.A., the owner of the registered trademark Gas-X® Extra Strength. The National Drug Code (NDC) for this product is 79481-0635-4.

Uses and Indications

This drug is indicated for the relief of pressure, bloating, and fullness commonly referred to as gas.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Patients should adhere strictly to the recommended dosage and administration guidelines. For adults and children aged 12 years and older, the recommended dose is 1 to 2 chewable tablets taken as needed after meals and at bedtime. It is imperative that the tablets are chewed or crushed completely before swallowing; they should not be swallowed whole.

The maximum allowable dosage for this population is 4 chewable tablets within a 24-hour period, unless otherwise directed by a healthcare professional. For children under 12 years of age, it is advised to consult a doctor before administration.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Therefore, no specific instructions regarding avoidance or non-use are necessary.

Warnings and Precautions

Healthcare professionals should be aware that the insert does not specify any particular warnings or general precautions associated with the use of this medication. Additionally, there are no laboratory tests required or suggested for safe use, nor are there instructions for obtaining emergency medical help or for discontinuing the medication and contacting a physician.

It is essential for healthcare providers to remain vigilant and monitor patients for any adverse effects or unusual symptoms that may arise during treatment, even in the absence of specified warnings or precautions. Regular patient assessments and open communication regarding any concerns are recommended to ensure safe and effective use of the medication.

Side Effects

Patients should be advised to keep this medication out of reach of children. There are no specific adverse reactions or side effects reported in clinical trials or postmarketing experiences associated with this medication. However, it is essential for healthcare providers to monitor patients for any unexpected reactions and to report them as necessary.

Drug Interactions

There are no documented drug interactions associated with the use of this medication. Additionally, there are no reported interactions between this drug and laboratory tests. As such, no specific dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Gas Relief (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Gas Relief.
Details

Pediatric Use

Pediatric patients should be kept out of reach of children. For adults and children aged 12 years and older, the recommended dosage is 1 or 2 chewable tablets as needed after meals and at bedtime, with a maximum of 4 chewable tablets in a 24-hour period unless otherwise directed by a healthcare professional.

For children under 12 years of age, it is advised to consult a doctor before use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of simethicone chewable tablets during pregnancy. As such, the safety of this medication in pregnant patients has not been established. There are no known dosage modifications or special precautions recommended for use during pregnancy. Healthcare professionals should weigh the potential benefits against any unknown risks when considering the use of simethicone in women of childbearing potential. It is advisable to consult with a healthcare provider for individualized recommendations.

Lactation

There are no specific warnings or recommendations regarding the use of simethicone in lactating mothers. Additionally, there is no information available about the potential for excretion of simethicone in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, respiratory depression, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Furthermore, specific antidotes or treatments may be indicated depending on the substance involved in the overdose. It is crucial for healthcare professionals to consult relevant clinical guidelines and toxicology resources to determine the most effective management strategies tailored to the individual patient's needs.

In summary, while no specific overdosage information is available, vigilance and prompt intervention are paramount in managing potential overdose situations.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important for patients to understand the potential risks associated with improper access to the medication by young individuals. Providers should emphasize the necessity of storing the medication in a secure location, away from children's sight and reach, to ensure safety.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at a controlled room temperature of 25°C (77°F), with permissible excursions between 15°-30°C (59°-86°F).

To ensure the integrity of the product, it must be protected from moisture. Additionally, the packaging is designed to be tamper-evident; therefore, the product should not be used if the outer package is opened or if the blister is torn or broken. Proper adherence to these storage and handling guidelines is crucial for maintaining product quality and safety.

Additional Clinical Information

The medication is administered orally. For adults and children aged 12 years and older, the recommended dosage is 1 or 2 chewable tablets as needed after meals and at bedtime, with a maximum of 4 chewable tablets in a 24-hour period unless otherwise directed by a physician. For children under 12 years, consultation with a doctor is advised prior to use.

Patients should be counseled to chew or crush the tablets completely before swallowing, as swallowing them whole is not recommended. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Gas Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Gas Relief, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.